Michele Melchiorre, COO, resigns from the Management Board

Vienna, Austria, 10 September 2018 – The Supervisory Board of Semperit AG Holding has today agreed to the request of Michele Melchiorre, COO and responsible Board Member for the Medical Sector, to terminate his Management Board contract as of 30 September 2018. Mr Melchiorre has decided to continue his career in the automotive industry, where he has previously worked for many years.

Dr Christoph Kollatz, Chairman of the Supervisory Board of Semperit AG Holding, states: “The Supervisory Board thanks Mr Melchiorre for his energetic commitment and regrets that he has prematurely terminated his Management Board mandate.”

The measures necessary for a fast reappointment to the Management Board position have already been introduced by the Supervisory Board. Until then, Dr Felix Fremerey, member of Semperit’s Supervisory Board, and CEO Dr Martin Füllenbach will be responsible for the Board portfolio of Michele Melchiorre on an interim basis. In this transition phase, Fremerey’s Supervisory Board mandate is suspended.

Dr Kollatz: “The ongoing restructuring process will continue seamlessly. The Supervisory Board supports the organisational realignment and wishes all those involved every success in achieving the goals we have set ourselves.”

About Semperit

The publicly listed company Semperit AG Holding is an internationally-oriented group that develops, produces, and sells highly specialised rubber and plastic products in more than 100 countries for the medical and industrial sectors: examination and surgical gloves, hydraulic and industrial hoses, conveyor belts, escalator handrails, construction profiles, cable car rings, and products for railway superstructures. The headquarters of this traditional Austrian company, which was founded in 1824, are located in Vienna. The Semperit Group employs around 6,900 people worldwide, including around 3,700 in Asia and around 900 in Austria (Vienna and production site in Wimpassing, Lower Austria). The group has 15 manufacturing facilities worldwide and numerous sales offices in Europe, Asia, Australia, and America. In 2017, the group generated sales of EUR 874.2 million and an adjusted EBITDA (without one-off effects) of EUR 35.8 million.